antiseizure pharm Flashcards
- Relate the postulated mechanisms underlying seizure pathophysiology for simple and complex partial, absence, tonic-clonic, and status epilepticus seizure disorders to the mechanisms of actions of the drugs of choice for their treatment. Focus on neurotransmitter systems and ion channels as drug targets.
➢ Grand Mal Seizures: Propagation carried out through
• DECREASE in GABA tone
• INCREASE in response to Glutamate
• INCREASE in sodium channel conduction
o Most drugs BLOCK the Na+ channels that propagate the spread throughout the brain in a use-dependent manner
• This use-dependence is important because when a seizure is not occurring, these drugs will have little effect on the brain
➢ Petit Mal Seizures: Related to strong coupling and oscillatory stimulation of thalamic and cortical neurons
• Generated by activation of low threshold-T type Ca++ channels (depolarization)
Simple Partial [10%]
- preservation of consciousness
- cortical origin in restricted region
Complex Partial [35%]
-Loss of or impaired consciousness
Secondary Generalization
- Loss of consciousness, include other areas/muscle groups
- Mechanism: Involves initiation (rather than propagation) - *difficult to treat
- List drugs of choice for the following seizure types: partial
(carbamazepine, lamotrigine, levetiracetam),
what is drug choice for grand mal/tonic clonic
(valproate, lamotrigine, levetiracetam)
what is drug choice for petit mal [absence]
(ethosuximide, valproic acid)
what is drug choice forstatus epilepticus
(benzodiazepines: diazepam-lorazepam-midazolam)
carbamazepine
drug of choice for partial seizures Strong inducer of CYP450 S/E -Diplopia-ataxia-sedation dose-related -GI upset -Rare but serious -Aplastic anemia-agranulocytosis monitor CBC -Hepatotoxicity monitor liver function tests
lamotrigine
Mechanism- Effects on VSSCs (suppress repetitive APs) and VSCCs ( Glu release) - broad spectrum
1st line for partial or generalized seizures - better tolerated than phenytoin or carbamazepine
ADRs
Similar to phenytoin (lower incidence): diplopia, ataxia, dizziness, skin rashes, sedation
levetiracetam (Keppra)
Mechanism - Efficacy
Precise mechanism unknown - affects Ca++ channels
1st line in treatment of generalized tonic-clonic seizures
ADRs
Somnolence, asthenia, dizziness
Low incidence of cognitive effects
valproate
Broad spectrum agent with efficacy against the most common seizure types
Inhibits metabolism of other AEDs: phenytoin, lamotrigine, carbamazepine, phenobarbital, ethosuximide
Adverse Drug Reactions
Dose-related GI upset (nausea-vomiting, pain)
Weight gain common
Black Box Warnings
-Hepatic failure deaths [increased risk
levetiracetam
Inhibits function of synaptic vesicle protein SV2A
Impairs Ca++-mediated neurotransmitter release - levetiracetam
ethosuximide
Decrease in low-threshold Ca++ (T-type) current
block abnormal Oscillatory currents in thalamic neurons in absence seizures
Drug of choice in absence seizures
Adverse Drug Reactions – generally few side effects
Dose-related gastric distress most common (nausea-vomiting, pain)
Less common: transient lethargy-fatigue, dizziness, headache
Phenobarbital
Neonatal status epilepticus
Adjunct for partial and tonic-clonic seizures
Metabolized slowly by P450 system - t1/2 of 4-5 days
Classic enzyme inducer
Adverse Drug Reactions
Irritability - overactivity in many children, sedative effects in others
Mild ataxia, nystagmus, skin rash, osteomalacia
May interfere with learning (cognitive deficits)
benzodiazepines (diazepam-lorazepam-midazolam)
Clonazepam (Klonopin)
Effective against absence seizures plus difficult cases: myoclonic seizures, infantile spasms, atonic seizures
ADRs: Sedation (> 50%), behavioral problems (25%)
Diazepam (Valium)
Drug of choice for status epilepticus [lorazepam (Ativan) and midazolam (Versed) also used]
Adjunctive therapy in atonic and absence seizures and infantile spasms
Ineffective after a few months (tolerance development)
ADRs: Somnolence - tolerance are limiting factors in chronic use
Which anticonvulsant drug is INCORRECTLY matched with its mechanism of action?
Valproic acid enhancement of GABA activity
Levetiracetam block of Ca++-mediated release of glutamate activity
Carbamazepine enhancement of GABA activity
Phenytoin block of VSSC suppress repetitive action potential
Ethosuximide block of T-type Ca++ channels in thalamocortical pathways
Diazepam block of VSSC suppress repetitive action potential
Diazepam block of VSSC suppress repetitive action potential
Carbamazepine enhancement of GABA activity
Patients should be carefully monitored for gingival hyperplasia if they are taking: Clozapine (Clozaril) Alprazolam (Xanax) Carbamazepine (Tegretol) Phenytoin (Dilantin ) Valproic acid (Depakote) Zolpidem (Ambien) Phenelzine (Nardil)
Phenytoin (Dilantin)